| MS Contin |
| Mvasi |
| Myalept |
| Myfembree |
| Myobloc |
| Naglazyme |
| Naprelan |
| Natpara |
| Neulasta and pegfilgrastim biosimilars Policy |
| Nexavar |
| Nexletol Nexlizet Policy 3647 A 02 2020 |
| Nexviazyme |
| Ninlaro |
| Nityr |
| Nolix (Brand Only) |
| Novarel |
| Novoeight |
| NovoSeven |
| Nplate |
| Nucynta ER |
